Clinical trial
An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan…
NCT00403481 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00403481 |
|---|---|
| Title | An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes |
| Official title | A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | olmesartan medoxomil, Olmesartan medoxomil plus Hydrochlorothiazide |
| Enrollment | 192 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 23, 2006 |
| Last update posted | Nov 3, 2016 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: